Filters
Hikma acquires Novugen’s FDA-approved ANDA for trametinib
Press Release, Product
Hikma signs exclusive licensing agreement with pharma& to bring innovative oncology treatment to MENA
Press Release, Business Development
Hikma launches Cisatracurium Besylate Injection, USP in the US
Press Release, Product
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg
Press Release, Product
Developing our pipeline in growing therapeutic areas
Story, Corporate
Expanding our patient reach across our markets
Story, Corporate
Leveraging our role as a leading healthcare provider in MENA
Story, Corporate
Providing access to clean water for families in Egypt
Story, Responsibility
Supporting food banks for those in need
Story, Responsibility
Hikma to host meet the management and site visit in Columbus, Ohio
Press Release, Corporate
Keeping patients safe is at the heart of everything we do
Story, Responsibility
Hikma receives FDA approval and launches Mercaptopurine Oral Suspension in the US
Press Release, Product